Hepatocellular carcinoma (HCC) is the most common primary tumour of the liver, responsible for significant morbidity and mortality worldwide. In the Western world, it primarily affects patients with cirrhosis, secondary to hepatitis C virus and alcoholism. In the rest of the world, HCC is closely associated with hepatitis B virus infections. Radiologists play a key role in accurately staging HCC, which has important implications for treatment planning. This pictorial review aims to describe the routes of HCC spread and the most frequent sites of metastases, to recognize extrahepatic HCC findings on computed tomography and magnetic resonance imaging, and to understand the implications of HCC staging on treatment planning.
Hepatocellular carcinoma (HCC) is the most common primary tumour of the liver [1] . Worldwide, an estimated 250,000 people die from the disease each year [2] . HCC develops in the setting of chronic liver disease. In the Western world, cirrhosis is present in 85%-90% of HCC cases, mostly associated with hepatitis C virus and alcoholism. The global distribution is closely linked to prevalence of hepatitis B virus [1] .
Pathophysiology of HCC Metastases
Extrahepatic HCC can occur in 1 of 3 ways: direct extension, hematogenous spread, or lymphatic invasion. Rupture of a HCC focus may result in intraperitoneal implantation of tumour cells onto peritoneal or omental surfaces [3] . Reported frequencies of HCC metastatic sites include lungs (55%), lymph nodes (53%), bone (28%), adrenal glands (11%), peritoneum and/or omentum (11%), and brain (2%). Rare sites of metastasis include the rectum, spleen, diaphragm, duodenum, esophagus, pancreas, seminal vesicle, and bladder [4] .
HCC Diagnosis and Treatment Options
Despite improvements in detection and treatment of HCC, the 5-year survival rate remains below 12% [5] . Many patients are diagnosed late in the disease, owing to the lack of unique symptoms and the liver's large functional reserve [6] . Guidelines from the American Association for the Study of Liver Diseases recommend screening with ultrasound in patients with known hepatitis B or cirrhosis due to other pathologies [6] . Hepatic lesions larger than 1 cm should be further evaluated with multidetector computed tomography (CT) or dynamic magnetic resonance imaging (MRI). Typical findings of HCC on CT or MRI are hypervascularity on the arterial phase with subsequent washout [6] . Atypical findings may require follow-up imaging or biopsy.
Several HCC staging systems are recognized. For patients with resectable disease, the American Joint Committee on Cancer classification system is considered most useful, based on tumour, node, and metastasis. In addition, hepatic function plays an integral role in treatment planning, generally classified according to the Child-Pugh system (A, well compensated; B, significant functional compromise; C, decompensated) [2] .
The best long-term survival is achieved through surgical management. However, only approximately 20% of patients are surgical candidates at initial diagnosis [2] . Spread to regional lymph nodes and distant metastases are definite contraindications for resection [6] . Nonsurgical patients are offered palliative locoregional therapies, including radiofrequency ablation, percutaneous ethanol injection, transarterial chemoembolization, and selective internal radiation therapy [6] . Radiofrequency ablation may have a role in the complete ablation of lesions smaller than 2 cm, but further studies are required before recommending it as a first-line approach for early HCC [6] .
Extrahepatic Findings of HCC
HCC has a predilection to directly invade veins, most commonly the portal, followed by the hepatic, and, lastly, the inferior vena cava (Figures 1-3) [7] . MRI can help to further characterize HCC lesions, which typically are low signal, precontrast, enhance on arterial phase, and washout on portal venous phase. The lungs are the most common site of HCC metastases, which occurs via hematogenous dissemination to the pulmonary capillary network [8] . This typically results in noncalcified soft-tissue nodules with lower lobe predominance and the same appearance as lung metastases from other primary tumours (Figures 4  and 5 ) [8] .
The second most common sites of spread are regional and distant lymph nodes with regional involvement significantly more common [4] . In a study of 403 patients with HCC, 41% had regional lymph node involvement, with 33% having affected the periceliac node, followed by portohepatic nodes at 23% ( Figure 6 ) [4] . Distant nodal metastases are most commonly reported in the mediastinum (Figure 7 ) [4] . When assessing lymphadenopathy, it is important to consider that patients with HCC often have hepatitis and/or cirrhosis, which is frequently associated with reactive lymphadenopathy. Vascularity, heterogeneity, and central necrosis should raise concern for malignancy.
Occasionally, bone metastasis is the initial presentation of HCC, which typically presents as skeletal pain or pathologic fractures [9] . In a study of 300 patients with HCC, 7.3% were found to have skeletal metastasis, with almost all having multiple bony lesions [10] . Bone metastases are typically lytic, hypervascular, and often expansile. The lumbosacral and thoracic spine are the most common sites [9] . Metastases to the ribs and ilium commonly have associated soft-tissue masses (Figure 8 ). Thoracic spine metastases may cause collapse of vertebral bodies, with extension into the spinal canal, which results in severe cord Figure 9 . A 48-year-old man with hepatocellular carcinoma and metastases to the thoracic spine. Coronal T2-weighted image, demonstrating nearcomplete collapse of T7 and T8 vertebral bodies (grey arrow). Extension into the spinal canal is causing severe cord compression, with high signal change, which extends from T6 to T9 (white arrow). Figure 10 . A 46-year-old man with hepatitis B and hepatocellular carcinoma. (A) Axial T1-weighted image, demonstrating low signal metastases that involves the right posterior superior iliac spine and the left sacral ala and body (thin arrows), with extension into the S1 and S2 neural foramina (curved arrow). (B) Axial T1-weighted image in the same patient, demonstrating invasion of the left acetabular roof (white arrow). compression (Figure 9 ). Bone metastases are best demonstrated as low signal lesions on T1-weighted sequences ( Figure 10 ).
HCC may disseminate to the peritoneum (Figure 11 ) and the omentum (Figure 12 ) through tumour cells in ascites, hematogenously through variceal collaterals, or by means of direct invasion from an exophytic tumour. HCC may also involve the falciform ligament [11] . The falciform ligament establishes a continuous pathway between the pancreatoduodenal area in the retroperitoneum and anterior abdominal wall. Adrenal involvement may be unilateral or bilateral ( Figure 13 ). The presence of an enlarged adrenal mass may not necessarily represent malignancy [4] . Even with known primary HCC, adrenal enlargement is statistically more likely to represent an adrenal adenoma [4] .
Enhancement of the adrenal metastasis can range from hypoattenuation, typical of adrenal metastases from primary tumours other than HCC, to marked enhancement. Central nervous system metastases are extremely rare, typically consisting of multiple, small enhancing masses at the greywhite matter junction ( Figure 14 ) [4] . Although the frequency of cardiac tumours is quite low, metastatic involvement is 40 times more prevalent than primary tumours [12] . HCC may spread via direct transvenous extension through the great veins.
Conclusion
HCC is an aggressive malignancy, and accurate staging is required for optimal treatment planning. Metastatic spread is by direct invasion, through ascites or via hematogenous or lymphatic routes. The most common sites of metastases include lung, followed by lymph nodes, bone, mesentery and/or omentum, adrenal glands, and brain. Because HCC can present initially as bulky extrahepatic disease, it is important to consider HCC as a primary source in the workup of malignancy [13] . Surgical resection is the treatment of choice for small unifocal tumours. Tumours that are confined to the liver but are not eligible for resection are treated with palliative locoregional therapies. Extrahepatic HCC carries a dismal prognosis in which only systemic treatment or supportive care is available. The radiologist plays a crucial role in the assessment of HCC staging, which will determine the best treatment for the patient. Figure 14 . A 71-year-old man with multifocal hepatocellular carcinoma who presented with a history of falls and dizziness. Axial contrast-enhanced computed tomography, demonstrating a large, rim-enhancing lesion in the left frontal lobe (grey arrow), with a significant amount of associated vasogenic oedema (white arrows).
